Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

Also called NCT03015909

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 116 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03015909
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03015909. Allocation not applicable; no masking; primary purpose treatment. Start 2016-08-11 (actual); primary completion 2017-12-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
Condition
Short Stature, Idiopathic
Condition
Infant, Small for Gestational Age
Condition
Growth Hormone Deficiency
Condition
Chronic Renal Failure
Condition
Turner Syndrome
Intervention (Drug)
Somatropin
Lead sponsor
LG Life Sciences (class: industry)

Record details

Record id
cardio:ct-nct03015909
Content hash
97bcf8907ff7a1ff6e710f474bf585a151ef9a3168fc788ec56517ed8728b543